Trial intelligence / Profile preview

Propolis Effects on Proteinuria and Kidney Function in CKD

NCT02766036Phase 2Completed

Sponsor
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Start
Dec 2016
Primary completion
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) comparing Propolis with Placebo (2 arms). Primary endpoint: Reducing Proteinuria at 1 year. Started Dec 2016; status: completed.

02

Drugs

propolis
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT02766036.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02766036.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call